Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine in Head and Neck Cancer Chemoradiation
NCT00503776Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jan 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in head and neck cancer (HNC), sponsored by Vanderbilt-Ingram Cancer Center. Started Jan 2006; status: terminated.
02
Drugs
amifostine
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00503776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503776.